
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Medical Incubator Japan K.K. is a venture capital firm established in 2018 and based in Tokyo, Japan. The firm specializes in investments within the healthcare sector, focusing on innovative startups that aim to improve patient outcomes and deliver returns to investors. It is registered with the Japan Agency for Medical Research and Development (AMED) under the 'Strengthening Program for Pharmaceutical Startup Ecosystem', highlighting its commitment to enhancing Japan's pharmaceutical startup landscape.
As of now, Medical Incubator Japan manages a portfolio of 11 companies and is recognized as a significant player in Japan's growing healthcare venture capital space. The firm actively participates in pitch events and collaborates with various stakeholders in the healthcare ecosystem to foster growth and innovation. Its office is located at JMF-Bldg. Akasaka 01, 1-11-28 Akasaka, Minato-ku, Tokyo 107-0052, Japan.
Medical Incubator Japan K.K. invests in both domestic and international startups that are developing first-in-class or best-in-class pharmaceuticals. The firm has a particular interest in areas such as regenerative medicine, gene therapy, and small molecules. Additionally, it supports startups that innovate medical services through devices and digital health solutions. The firm seeks to partner with companies that have the potential to transform the standard of care in healthcare.
Investment checks typically range from seed to Series A stages, allowing the firm to engage with early-stage companies that show promise in their respective fields. Medical Incubator Japan emphasizes the importance of a strong founding team and innovative approaches to healthcare challenges, which are critical factors in their investment decisions. The firm also values collaboration and often integrates its portfolio companies into a broader ecosystem to enhance their growth potential.
Medical Incubator Japan K.K. has built a diverse portfolio of 11 notable companies, each contributing to advancements in healthcare:
秦 充洋 (Mitsuhiro Hata) - Chairman. Mitsuhiro has extensive experience in the healthcare investment sector and has been instrumental in shaping the firm's strategic direction.
桂 淳 (Jun Katsura) - CEO. Jun leads the firm with a focus on identifying and supporting innovative healthcare startups.
原田 謙治 (Kenji Harada) - Investment Officer. Kenji specializes in evaluating investment opportunities and managing portfolio companies.
安江 滋 (Shigeru Yasunaka) - Investment Officer. Shigeru brings expertise in healthcare technology and investment strategies.
駒澤 明日香 (Asuka Komazawa) - Principal. Asuka focuses on sourcing new deals and supporting portfolio growth.
唐 瓏 (Ryo Karu) - Principal. Ryo has a background in biotech investments and assists in due diligence processes.
栗原 大 (Hiroshi Kurihara) - Principal. Hiroshi contributes to investment strategy and portfolio management.
村井 丹 (Tamaki Murai) - Fund Management Manager. Tamaki oversees fund operations and investor relations.
田中 龍夫 (Tatsuo Tanaka) - Auditor. Tatsuo ensures compliance and financial integrity within the firm.
川原 正行 (Masayuki Kawahara) - Specialist. Masayuki provides insights into market trends and investment opportunities.
金川 幸紀 (Yuki Kanekawa) - Specialist. Yuki focuses on healthcare innovation and technology.
Roy Fonarov - Specialist. Roy brings a wealth of knowledge in healthcare investments and strategic partnerships.
To pitch Medical Incubator Japan K.K., startups should visit their website at medicalincubatorjapan.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. The firm values clarity and detail in presentations.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
As of March 2023, Medical Incubator Japan K.K. continues to expand its portfolio, focusing on innovative healthcare startups. The firm has been actively participating in pitch events organized by LINK-J, aimed at generating Japanese medical unicorns.
In recent months, the firm has also been recognized for its role in the 'Strengthening Program for Pharmaceutical Startup Ecosystem' by AMED, which underscores its commitment to supporting the growth of the pharmaceutical sector in Japan.
What are the investment criteria for Medical Incubator Japan?
The firm invests in startups developing first-in-class or best-in-class pharmaceuticals, particularly in regenerative medicine, gene therapy, and digital health services. They look for innovative solutions that can transform patient care.
How can startups apply or pitch to Medical Incubator Japan?
Startups can pitch through the firm's website at medicalincubatorjapan.com. It is advisable to include a detailed business plan and information about the founding team in the pitch deck.
What makes Medical Incubator Japan different from other VCs?
Medical Incubator Japan is uniquely positioned as a government-registered VC under AMED, which provides formal recognition and access to a network of healthcare stakeholders in Japan. This enhances their ability to support portfolio companies.
What is the geographic scope of Medical Incubator Japan's investments?
The firm primarily focuses on startups based in Japan and Asia, but it also considers international companies that align with its investment thesis.
What is the typical check size for investments?
Medical Incubator Japan typically invests at the seed to Series A stages, with check sizes varying based on the specific needs and potential of the startup.
What kind of post-investment involvement does Medical Incubator Japan have?
The firm provides strategic support to its portfolio companies, leveraging its connections within the healthcare ecosystem to foster growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.